Innate immune system gene polymorphisms in maternal and child genotype and risk of preterm delivery

Jones, Nicole M.; Holzman, Claudia; Tian, Yan; Witkin, Steven S.; Genc, Mehmet; Friderici, Karen; Fisher, Rachel; Sezen, Devrim; Babula, Oksana; Jernigan, Katherine A.; Chung, Hwan; Wirth, Julia

doi:10.3109/14767058.2011.569614

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Innate immune system gene polymorphisms in maternal and child genotype and risk of preterm delivery

Published Date:

Jun 01 2011

Publisher's site:

http://dx.doi.org/10.3109/14767058.2011.569614

Source:

J Matern Fetal Neonatal Med. 25(3):240-247.

[PDF-283.79 KB]

Details:

Alternative Title:

J Matern Fetal Neonatal Med

Personal Author:

Jones, Nicole M. ; Holzman, Claudia ; Tian, Yan ; Witkin, Steven S. ; Genc, Mehmet ; ... More ▼

Description:

Objective There is little information about the combination of genetic variability in pregnant women and their children in relation to the risk of preterm delivery (PTD). In a sub-cohort of 487 non-Hispanic white and 288 African-American mother/child pairs, the Pregnancy Outcomes and Community Health Study assessed ten functional polymorphisms in nine genes involved in innate immune function. Methods Race-stratified weighted logistic regression models were used to calculate odds ratios for genotype and PTD/PTD subtypes. Polymorphisms significantly associated with PTD/PTD subtypes were tested for mother/child genotype interactions. Results Three maternal polymorphisms (IL-1 receptor antagonist intron two repeat (IL-1RN), matrix metalloproteinase-9 -C1562T, and TNF receptor two T198G (TNFR2)) and three child polymorphisms (IL1-RN, tumor necrosis factor-alpha -G308A, and TNFR2) were associated with PTD, but associations varied by PTD subtype and race. Two interactions were detected for maternal and child genotype. Among non-Hispanic white women, the odds of PTD was higher when both mother and child carried the IL-1RN allele two (additive interaction p<.05). Among African-American women, the odds of PTD was higher when both mother and child carried the TNFR2 G allele (multiplicative interaction p<.05). Conclusion These results highlight the importance of assessing both maternal and child genotype in relation to PTD risk.

Subject:

[+]

Pubmed ID:

21627550

Pubmed Central ID:

PMC4643033

Document Type:

Journal Article

Funding:

R01 HD 34543-01/HD/NICHD NIH HHS/United States ; R01 HD034543/HD/NICHD NIH HHS/United States ; R01 HD034543-07/HD/NICHD NIH HHS/United States ; R01 HD34543/HD/NICHD NIH HHS/United States ; T32 HD046377/HD/NICHD NIH HHS/United States ; ... More ▼

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

nihms434484.nxml

application/octet-stream

No Related Documents.

You May Also Like:

Vital signs : Clinical characteristics of patients with confirmed acute flaccid myelitis, United States, 2018

Personal Author:

Kidd, Sarah; Lopez, Adriana; Nix, W. Allan; Anyalechi, Gloria; Itoh, Megumi; Yee, Eileen; Oberste, M. Steven; Routh, Janell;

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.. Center for Global Health (U.S.). Division of Global HIV and TB..

Published Date:

August 4, 2020

Series:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, August 4, 2020
CDC Vital signs ; AUG 2020

Description:

What is already known about this topic? Since U.S. surveillance for acute flaccid myelitis (AFM) began in 2014, reported cases have peaked biennially. Most cases occur in children during late summer and early fall.What is added by this report? Among ...

File Type:

[PDF - 274.88 KB]
SARS-CoV-2 transmission and infection among attendees of an overnight Camp — Georgia, June 2020

Personal Author:

Szablewski, Christine M.; Chang, Karen T.; Brown, Marie M.; Chu, Victoria T.; Yousaf, Anna R.; Anyalechi, Ndubuisi; Aryee, Peter A.; Kirking, Hannah L.; Lumsden, Maranda; Mayweather, Erin; McDaniel, Clinton J.; Montierth, Robert; Mohammed, Asfia; Schwartz, Noah G.; Shah, Jaina A.; Tate, Jacqueline E.; Dirlikov, Emilio; Drenzek, Cherie; Lanzieri, Tatiana M.; Stewart, Rebekah J.;

Corporate Authors:

Georgia. Department of Public Health.. CDC COVID-19 Response Team.. Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service..

Published Date:

July 31, 2020

Series:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, July 31, 2020

Description:

Limited data are available about transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), among youths. During June 17–20, an overnight camp in Georgia (camp A) held orientation for 138 trainees and 120 staff members; ...

File Type:

[PDF - 132.23 KB]
Public health guidance for community-related exposure

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

July 31, 2020

Series:

Coronavirus Disease 2020 (COVID-19)
Get and keep America open

Description:

Updated July 31, 2020The following guidance is provided for definitions and management of contacts of people with COVID-19. Separate guidance is available for international travelers. Healthcare personnel (HCP) should follow CDC’s Interim U.S. Guid...

File Type:

[PDF - 633.74 KB]
How to report COVID-19 laboratory data

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

July 31, 2020

Series:

Coronavirus Disease 2020 (COVID-19)

Description:

Updated July 31, 2020The public health response to COVID-19 depends on comprehensive laboratory testing data. These data will contribute to understanding disease incidence and testing coverage, and can contribute to the identification of supply chain...

File Type:

[PDF - 678.51 KB]
U.S. clinical laboratories reporting SARS-CoV-2 test results to CDC : updated July 31, 2020

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Published Date:

July 31, 2020

Series:

COVIDView

Description:

U.S. Clinical Laboratories Reporting SARS-CoV-2 Test Results to CDCMarch 8, 2020 – July 25, 2020Data as of July 30, 2020

File Type:

[PDF - 393.72 KB]